Skip to main content
Journal cover image

Surrogate markers of effective anti-tumor immunity.

Publication ,  Other
Lyerly, HK; Morse, MA; Clay, TM
Published in: Ann Surg Oncol
April 2001

Duke Scholars

Published In

Ann Surg Oncol

DOI

ISSN

1068-9265

Publication Date

April 2001

Volume

8

Issue

3

Start / End Page

190 / 191

Location

United States

Related Subject Headings

  • Prognosis
  • Oncology & Carcinogenesis
  • Neoplasms
  • Immunotherapy
  • Humans
  • Cancer Vaccines
  • Biomarkers
  • Antigens, Neoplasm
  • 3211 Oncology and carcinogenesis
  • 1112 Oncology and Carcinogenesis
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Lyerly, H. K., Morse, M. A., & Clay, T. M. (2001). Surrogate markers of effective anti-tumor immunity. Ann Surg Oncol. United States. https://doi.org/10.1007/s10434-001-0190-6
Lyerly, H. K., M. A. Morse, and T. M. Clay. “Surrogate markers of effective anti-tumor immunity.Ann Surg Oncol, April 2001. https://doi.org/10.1007/s10434-001-0190-6.
Lyerly HK, Morse MA, Clay TM. Surrogate markers of effective anti-tumor immunity. Vol. 8, Ann Surg Oncol. 2001. p. 190–1.
Lyerly, H. K., et al. “Surrogate markers of effective anti-tumor immunity.Ann Surg Oncol, vol. 8, no. 3, Apr. 2001, pp. 190–91. Pubmed, doi:10.1007/s10434-001-0190-6.
Lyerly HK, Morse MA, Clay TM. Surrogate markers of effective anti-tumor immunity. Ann Surg Oncol. 2001. p. 190–191.
Journal cover image

Published In

Ann Surg Oncol

DOI

ISSN

1068-9265

Publication Date

April 2001

Volume

8

Issue

3

Start / End Page

190 / 191

Location

United States

Related Subject Headings

  • Prognosis
  • Oncology & Carcinogenesis
  • Neoplasms
  • Immunotherapy
  • Humans
  • Cancer Vaccines
  • Biomarkers
  • Antigens, Neoplasm
  • 3211 Oncology and carcinogenesis
  • 1112 Oncology and Carcinogenesis